10:04 AM EST - Oncolytics Biotech® Inc. : Announced that it received written notice from NASDAQ stating that its minimum bid price deficiency has been cured, it is in compliance with the applicable listing standard and the matter is now closed.Oncolytics had previously been notified by Nasdaq on September 17, 2019 that it was not in compliance with the minimum bid price rule because its common stock failed to meet the closing bid price of $1.00 or more for 30 consecutive business days. In order to regain compliance with Listing Rule 5550(a), the Company was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days. Oncolytics Biotech® Inc.
shares T.ONC are trading up $0.06 at $1.54.
